Insights & Resources
For Life Sciences Professionals.

Whether you’re a healthcare professional, a researcher, or simply interested in drug development, you’ll find valuable information and resources here that can help you stay informed and make informed decisions. Let us know what else you’d like to hear about!

Featured Insights

Case Study International & Local PVMI Service cover image

Case Study: International & Local Pharmacovigilance/Medical Information Services Urgent Action

Blog Marketing Pharmaceutical Products in CIS Eurasian Economic Union

Marketing Pharmaceutical Products in CIS/EAEU

Explore regulatory differences from the EU, recent legislative changes, and practical RA & PV considerations.

Blog Pharmacovigilance and Medical Information Outsourcing Benefits for Biotech

PV & MI Outsourcing Benefits for Biotech

Learn how PV/MI outsourcing enables biotechs to reduce costs, scale efficiently, strengthen compliance, and accelerate market readiness.

How to prepare for Affiliate-Based Outsourcing for Regulatory Affairs?

How to prepare for Affiliate-Based Outsourcing for Regulatory Affairs?

Webinar: How to prepare for Affiliate-Based Outsourcing for Regulatory Affairs? Affiliate-Based Outsourcing (ABO) ...
Setting Up A Pharmacovigilance System

Setting Up A Pharmacovigilance System

Setting Up a Pharmacovigilance System from Scratch In the EU/EEA, US, and other major pharmaceutical markets, you ...
Centralized Procedure in the GCC Region

Centralized Procedure in the GCC Region

The Centralized Procedure in the GCC Region describes the possibility to register pharmaceutical products ...
Must-Know Legislation for Medical Device Registration in the EAEU

Must-Know Legislation for Medical Device Registration in the EAEU

EAEU legislation for Medical Device registration has been continuously updating for the last six years since the ...
Strategic Pharmacovigilance Outsourcing Models

Strategic Pharmacovigilance Outsourcing Models

Larger companies often limit their strategic pharmacovigilance activities outsourcing only to highly manual and ...
Medical Device Registration in the Eurasian Economic Union (EAEU)(Part 2)

Medical Device Registration in the Eurasian Economic Union (EAEU)(Part 2)

How do you realize Medical Device Registration in the Eurasian Economic Union (EAEU)? Learn about EAEU Conformity Assessment Routes and MRP.
Advantages of QPPV Outsourcing in the EU/EEA

Advantages of QPPV Outsourcing in the EU/EEA

Advantages of QPPV Outsourcing in the EU/EEA Pharmaceutical companies with a primary base outside the EU, ...
Affiliate Based Outsourcing for Regulatory Affairs

Affiliate Based Outsourcing for Regulatory Affairs

Practical tips on Affiliate Based Outsourcing including for Regulatory Affairsoptimization of local RA setup, management and relevant costs.
7 Reasons To Include Eastern Europe In Your Clinical Trial Strategy

7 Reasons To Include Eastern Europe In Your Clinical Trial Strategy

Choosing the right set of countries, sites and investigators for a clinical trial are critical success factors in ...
Company Registration Requirements in MENA: a Prerequisite for Product Registration

Company Registration Requirements in MENA: a Prerequisite for Product Registration

Company registration is part of the common regulatory requirements in several Middle Eastern and North African ...
Biosimilars in the MENA Region: Regulatory Landscape

Biosimilars in the MENA Region: Regulatory Landscape

Regulatory affairs for biosimilars in Middle East North Africa (MENA) region are evolving as existing guidelines ...
Successful Medical Device Registration in EAEU: New Legislation (Part 1)

Successful Medical Device Registration in EAEU: New Legislation (Part 1)

Webinar: Successful Medical Device Registration in EAEU: New Legislation (Part 1) The webinar discusses and ...
Saudi FDA’s New Pricing Guidelines and Impact on the Region

Saudi FDA’s New Pricing Guidelines and Impact on the Region

In a highly evolving regional pricing environment, Saudi Arabia (KSA) is no exception. The Saudi Food and Drug Authority (SFDA) has been periodically reviewing its pricing mechanisms and criteria so that the country becomes a regional reference for the prices of pharmaceutical products. What followed is a change in the pricing strategy by SFDA and a shift from price takers to price makers.
Webinar: Regulatory Strategy in the EAEU and Rest of CIS Countries

Webinar: Regulatory Strategy in the EAEU and Rest of CIS Countries

Regulatory strategy in EAEU and CIS regions differ from other regions as market access to these countries can be a ...
CMC: Effective Writing Of IND And IMPD

CMC: Effective Writing Of IND And IMPD

This artical focuses on best practices in delivering an effective CMC writing strategy when writing an IND or IMPD.
Webinar: Effective IMPD Writing. The Quality Part

Webinar: Effective IMPD Writing. The Quality Part

Effective IMPD writing, including the quality part is a vital document that contains information about an ...
Clinical Study Start-Up: Is there any Difference Between Western and Eastern Europe?

Clinical Study Start-Up: Is there any Difference Between Western and Eastern Europe?

This article reviews Clinical Study Start-up Differences Between West & East Europe, timelines, and processes. ...
Expediting access through Reliance Pathways: MENA region

Expediting access through Reliance Pathways: MENA region

Reliance models are review pathways used by Regulators to expedite the patient access to essential pharmaceutical products and to overcome resource constraints and priorities. Recently, several National Competent Authorities (NCA) in the Middle East North Africa (MENA) region have implemented the Abridged and Verification reviews. These regulatory procedures allow the approvement of needed innovative and/or life-saving drugs.
Webinar: eCTD Submission Strategies. In-house vs. Outsourcing

Webinar: eCTD Submission Strategies. In-house vs. Outsourcing

eCTD Submission Strategies, including outsourcing, are influenced by varying requirements in various regions ...
3 Factors Affecting the Successful Collection of Drug Safety Information in Social Networking Sites

3 Factors Affecting the Successful Collection of Drug Safety Information in Social Networking Sites

Health information that has been posted online by patients can efficiently supplement your post-marketing drug ...

Big Enough To Cover All Your Needs.
Small Enough To Care.

Discover how Biomapas provides all the support to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Reliable support for every phase of your clinical trial, from recruitment to results.

Pharmacovigilance

Flexible safety monitoring to keep your products compliant and trusted.

Regulatory Affairs

Confidently navigate regulatory challenges with expert support.

Medical Information

Clear, accurate medical information 24/7, tailored for global audiences.

CMC

Expert CMC support to take your product from development to approval with confidence.

Quality Assurance

Export auditors help identify gaps and close them with actionable solutions.